$30.35
-1.7%The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors, who are independent or who require some support. As of December 31, 2021, the company operated 88 home health and hospice agencies, and 54 senior living communities with 4127 Senior Living units in Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.
Chief Clinical Officer
Compensation
$743,252
Chief Executive Officer & Chairman
Compensation
$2,024,068
Chief Financial Officer
Compensation
$1,214,522
Executive Vice President, General Counsel & Corporate Secretary
Compensation
$766,282
President & Chief Operating Officer
Compensation
$1,604,172
President of Cornerstone Healthcare
During the last 12 months, insiders have purchased $114K and sold $115K worth of PNTG shares, resulting in $1K of net selling activity.
0
0.00
22
766.00
-766
-$766
0
0.00
0
0.00
+0
+$0
10.0K
113.50K
0
0.00
+114K
+$114K
0
0.00
4.9K
113.77K
-114K
-$114K
Smith Barry M
Director
$114K
Guerisoli Brent
Officer: Chief Executive Officer
$94K
Cheney Kirk Sterling
Officer: Evp, Gc And Corp Secy
$21K
Slightly bearish with $1K net selling. Selling modestly exceeds buying, which could be routine diversification rather than concern.
Moderately negative ratio. Selling is roughly double the buying, which may be routine or signal caution.
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
2 insider sellers vs. 1 buyers. More insiders selling than buying suggests cautious or negative sentiment.
Balanced insider activity: Roughly equal buying and selling suggests normal portfolio management rather than strong directional signals. Look to other metrics for clearer investment insights.
PNTG - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | March 31, 2026 | May 14, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 17, 2025 | May 16, 2025 | 2025 | |
DEF 14A DEF 14A 2023 N/A | April 11, 2024 | December 31, 2023 | 2023 | |
DEF 14A DEF 14A N/A | April 13, 2023 | April 13, 2023 | ||
DEF 14A DEF 14A 2021 N/A | April 14, 2022 | December 31, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | April 13, 2021 | December 31, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | April 14, 2020 | December 31, 2019 | 2019 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.